Are you Dr. Gelfand?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 49 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3333 Burnet Ave
ML 5031
Cincinnati, OH 45229Phone+1 513-636-4251Fax+1 513-636-8145
Summary
- Dr. Michael Gelfand, MD is a board certified nuclear medicine physician in Cincinnati, Ohio. He is currently licensed to practice medicine in Ohio, Tennessee, and Kentucky. He is affiliated with Cincinnati Children's Hospital Medical Center and Shriners Children's Ohio.
Education & Training
- Christ HospitalResidency, Nuclear Medicine, 1975 - 1978
- Cincinnati Children's Hospital Medical CenterResidency, Pediatrics, 1974 - 1975
- Cincinnati Childrens Hospital Medical CenterInternship, Transitional Year, 1973 - 1974
- Stanford University School of MedicineClass of 1971
Certifications & Licensure
- OH State Medical License 1974 - 2023
- KY State Medical License 2004 - 2019
- TN State Medical License 2008 - 2015
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Pediatrics Pediatrics
Clinical Trials
- [F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children Start of enrollment: 2013 Feb 01
- I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma Start of enrollment: 1991 Jan 01
Publications & Presentations
PubMed
- 169 citationsIncentive spirometry to prevent acute pulmonary complications in sickle cell diseases.Paul S. Bellet, Karen Kalinyak, Rakesh Shukla, Michael J. Gelfand, Donald L. Rucknagel
The New England Journal of Medicine. 1995-09-14 - 39 citationsValidation of Postinduction Curie Scores in High-Risk Neuroblastoma: A Children's Oncology Group and SIOPEN Group Report on SIOPEN/HR-NBL1.Gregory A. Yanik, Marguerite T. Parisi, Arlene Naranjo, Helen Nadel, Michael J. Gelfand
Journal of Nuclear Medicine. 2018-03-01 - 55 citationsAltered mesolimbocortical and thalamic dopamine in Tourette syndromeDonald L. Gilbert, Bradley T. Christian, Michael J. Gelfand, B. Shi, Joseph Mantil
Neurology. 2006-11-14